Skip to main content

Table 2 Patient characteristics and diagnostic studies, baseline

From: Expanded access with intravenous hydroxypropyl-β-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis

Patient identification

Gender

Age at diagnosis

Signs/Symptoms at diagnosis

Diagnostic tests NPC1 filipin/Genotype

Miglustat treatment

SEQ1

Female

3 years

Splenomegaly, pancytopenia, cognitive impairment

Cultured fibroblast, positive filipin; genotype heterozygous for c.1920delG exon 12 and IVS9 c.1554-1009G > A missense mutation

yes

SEQ2

Female

3 years

Splenomegaly, pancytopenia, cognitive impairment

Cultured fibroblast, positive filipin; genotype heterozygous for c.1920delG exon 12 and IVS9 c.1554-1009G > A missense mutation

yes

SEQ3

Female

7 years

Cognitive impairment

Cultured fibroblast, equivocal filipin; genotype heterozygous for c.1552C > T, p.R518W (p.ARG518Trp) in exon 9 and c.2594C > T, p.5865 L (p.Ser865Leu) in exon 17

yes

SEQ4

Female

5 years

Ataxia

Cultured fibroblast, equivocal filipin; genotype heterozygous for c.1552C > T, p.R518W (p.ARG518Trp) in exon 9 and c.2594C > T, p.5865 L (p.Ser865Leu) in exon 17

yes

SEQ5

Male

10 years

Dysarthria, cognitive impairment, anxiety, hypotonia, VSGP

Cultured fibroblast, positive filipin; genotype heterozygous for R978C missense and IVS21–2 A > G splice site mutation

yes

SEQ6

Female

7 years

Splenomegaly, VSGP

Cultured fibroblast, positive filipin; genotype heterozygous for R978C missense and IVS21–2 A > G splice site mutation

Yes

SEQ7

Male

2 years

Neonatal hepatosplenomegaly, conjugated hyperbilirubinemia, hypotonia, global developmental delay, failure to thrive

Cultured fibroblast, positive filipin; Genotype heterozygous for c.2008_2011delITGCT and c.3565_3566insG

yes

SEQ8

Female

1 year

Liver dysfunction, cholestatic jaundice, hepatosplenomegaly, developmental delay

Genotype heterozygous for c.2213C > A and c.3234_3237dupATTT

Yes

SEQ9

Female

20 years

Cognitive decline, ataxia, hepatosplenomegaly

Cultured fibroblast, positive filipin; Genotype heterozygous for c.688_69delTCTGTG and c.3182 T > C

No

IV1

Female

8 months

Hepatosplenomegaly, liver fibrosis, difficulty feeding

Cultured fibroblast, positive filipin; Genotype heterozygous for p.I923V and A1151T (c.2767A > G/3541G > A)

No

IV2

Male

15 years

Hepatosplenomegaly, behavioral disturbance, epilepsy, cognitive decline

LS-509 biomarker normal; Confirmed NPC1 gene mutation, results not available

yes

IV3

Female

16 years

Liver dysfunction at birth, hepatosplenomegaly, schizophrenia

LS-509 biomarker increased; genotype not available

yes

  1. SEQ1–9: patients received intravenous followed by addition of intrathecal treatment
  2. IV1–3: patients received intravenous treatment only
  3. VSGP vertical supranuclear gaze palsy